The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
As the communities that border this interface are large and diverse, the scope of
In leveraging the editorial leadership from Cell and The Lancet together with the publishing expertise of Elsevier to create a unique forum for the reputable and speedy publication of research in life and health sciences, we are committed to facilitating and incentivizing a robust and successful pipeline for improved human health globally.
EClinicalMedicine is a new open access clinical journal that will publish original research to help frontline health professionals navigate the complex and rapid health transitions facing societies worldwide. EClinicalMedicine will help practitioners solve the problems and challenges of healthcare across all communities. From diagnosis to treatment, prevention to health promotion and protection, it will integrate disciplines across all specialties and across the life course with the ultimate goal of strengthening health systems as core institutions in our societies. It is a journal that has the courage and vision to rethink and reframe the future of health and healthcare.
Reflecting the increasing importance of endovascular techniques in the management of vascular diseases and the value of closer collaboration between the vascular surgeon and the vascular radiologist, the journal has now extended its scope to encompass the growing number of contributions from this exciting field. Articles describing endovascular method and their critical evaluation are included, as well as reports on the emerging technology associated with this field.
Contributions are also included from such associated specialities as angiology, diabetology, rehabilitation and other fundamental sciences, provided these relate to the management of vascular patients.
To order this journal online, visit